Weekly Policy Update: FDA Releases New Draft Guidance and the Midwest BIO CSBA Retreat
By: Colorado BioScience Association Date: 08/17/2018
FDA Releases New Draft Guidance to advance and modernize oncology drug trials In the FDA’s ongoing effort to modernize and create a more efficient approval process, last Friday the FDA released their...
Learn MoreWeekly Policy Update: FDA Funding and Other News
By: Colorado BioScience Association Date: 08/10/2018
FDA Receives Funding in Senate Passed Appropriations Bill Last week the U.S. Senate overwhelmingly passed a $154.2 billion spending bill that includes more than $3 billion for the FDA. When industry f...
Learn MoreWeekly Policy Update: Medical Device Tax and Colorado State Budget
By: Colorado BioScience Association Date: 08/03/2018
Scott Larson, VP, Legal and General Counsel, Terumo BCT; Jenna Hutchins, Territory Manager, ResMed; Congresswoman Dianna Degette; April Giles, President, CBSA; Jonathan Toronto, Vice President,...
Learn MoreWeekly Policy Update: House Repeals Medical Device Tax
By: Colorado BioScience Association Date: 07/27/2018
On behalf of Colorado BioScience Association thank you for your efforts to secure a yes vote on H.R. 184 - Protect Medical Innovation Act of 2017. We appreciate the time you took to advocate to your r...
Learn MoreWeekly Policy Update: Full Repeal of the Medical Device Tax Advocacy
By: Colorado BioScience Association Date: 07/20/2018
This has been another week with persistent advocacy for full repeal of the Medical device tax in standalone legislation. A permanent repeal of the medical device excise tax remains a top priority for...
Learn MoreColorado BioScience Association Announces Departure of President & CEO, April Giles
By: Colorado BioScience Association Date: 07/16/2018
Board of Directors to Begin National Search for Replacement DENVER – Colorado BioScience Association (CBSA) announces the departure of longtime President & CEO April Giles. She served CBSA for mor...
Learn MoreWeekly Policy Update: Medical Device Tax Advocacy and the CACI Legislative Candidate Interviews
By: Colorado BioScience Association Date: 07/13/2018
CBSA continues to advocate for a full repeal of the Medical device tax in standalone legislation. A permanent repeal of the tax remains a top priority for CBSA and Colorado's medtech innovators. While...
Learn MoreWeekly Policy Update: Meeting with Congresswoman Degette
By: Colorado BioScience Association Date: 07/06/2018
This week Colorado BioScience Association along with AdvaMed, our Board Chair Scott Larson at Terumo BCT, Zimmer Biomet and ResMed met with Congresswoman DeGette. The meeting offered a great opportuni...
Learn MoreWeekly Policy Update: Primary Elections, Congratulating Sen. Gardner, and Drug Pricing
By: Colorado BioScience Association Date: 06/28/2018
2018 COLORADO PRIMARY ELECTION With the anticipated Colorado Primary Election this week, we learned the long-awaited results of who would be our top two democratic and republican candidates for Govern...
Learn MoreWeekly Policy Update: FDA Releases Important Guidances
By: Colorado BioScience Association Date: 06/21/2018
The FDA recently announced the release of important guidances, “Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities–Questions and Answers,” and “Medical...
Learn More